XFXin Feng

Xin Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xin Feng has a total of 255 co-authors. Here are the top co-authors by number of shared publications:

  • Chuanzhi Duan

    Zhujiang Hospital, Southern Medical University

    16 shared publications
  • Aihua Liu

    Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University

    12 shared publications
  • Xin Zhang

    Neurosurgery Center, Department of Cerebrovascular Surgery, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, People’s Republic of China

    10 shared publications
  • Anqi Xu

    9 shared publications
  • Chi Huang

    Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    9 shared publications
  • Hao Yuan

    Neurosurgery Center, Department of Cerebrovascular Surgery, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, People’s Republic of China

    9 shared publications

Latest Publications

  • Comparison of braided versus laser-cut stent placement for ruptured intracranial aneurysms in the acute phase: a propensity score matched study

    by Yingxue Luo, Yitong Zhao, Chi Huang, Jiwan Huang, Xueyan Deng, Gege Shang, Xin Feng, Xifeng Li, Shixing Su, Chuanzhi Duan

  • Open Access

    Low-Dose Glucocorticoids Adjunctive to Flow Diverter Therapy for Unruptured Intracranial Aneurysms Improve Cerebrovascular Outcomes

    by Zhuohua Wen, Xiheng Chen, Xin Tong, Chi Huang, Mengshi Huang, Jiancheng Lin, Anqi Xu, Hanyan Yang, Xiru Zhang, Yuanqi Lin, et al.

    Flow diverter (FD) implantation is standard for unruptured intracranial aneurysms (UIAs), but cerebrovascular complications persist. This nested study within a prospective multicenter cohort evaluates whether short-term, low-dose glucocorticoid use is associated with cerebrovascular outcomes after FD implantation. Propensity-score matching with exact matching on UIA location yielded 1327 patients (360 glucocorticoid-treated; 967 controls). Intravenous glucocorticoids, initiated within 2 hours of the FD procedure and administered for ≥2 days, were associated with fewer in-hospital cerebrovascular events (6.9% vs. 13.1%; adjusted odds ratio [aOR], 0.53) and major cerebrovascular events (4.7% vs. 12.4%; aOR, 0.37). Over a median 2-year follow-up, glucocorticoid use was also associated with fewer new-onset major cerebrovascular events (3.6% vs. 8.7%; adjusted hazard ratio, 0.41) and less in-stent stenosis (7.9% vs. 13.2%; aOR, 0.55). Findings remained robust in unmatched patients on sensitivity analyses. We demonstrate that perioperative glucocorticoid regimens may reduce cerebrovascular events and in-stent stenosis in FD-treated patients, warranting randomized trials.

  • Open Access

    AICAR-induced energy supply and paracrine activity of endothelial cells accelerate chronic diabetic wound healing by promoting angiogenesis and modulating macrophage reprogramming

    by Hengxian Su, Chang Liu, Yusheng Cheng, Wenping Cheng, Anqi Xu, Daoyuan Hu, Hongyu Shi, Mengshi Huang, Hao Yuan, Chi Huang, et al.

  • Pipeline Shield versus Pipeline Flex for unruptured intracranial aneurysms: a propensity-matched multicenter study

    by Runze Ge, Chao Peng, Wenxin Chen, Guangzhong Chen, Can Li, Peifeng Guan, Lele Dai, Zhuohua Wen, Chi Huang, Jiwan Huang, et al.

    Background Pipeline Flex Embolization Device with Shield Technology (PED Shield) is designed to reduce the incidence of thrombosis events through phosphorylcholine coating. However, the comparative efficacy and safety of PED Shield and PED/PED Flex remain unclear. Methods We conducted a retrospective analysis of a prospectively maintained database at three advanced stroke centers from February 2016 to October 2024. Propensity score matching was employed to adjust for sex, age, hypertension, diabetes, hyperlipidemia, smoking, aneurysm location, morphology, size, coiling and follow-up duration. After matching, perioperative complications and clinical and angiographic outcomes were compared. Results 1039 patients treated by PED/PED Flex and 172 patients treated by PED Shield were enrolled. For clinical outcomes, 164 pairs were matched. No significant differences were found in total perioperative complications (7.9% vs. 4.9%, p = 0.259) and favourable prognosis (mRS score 0–2, 98.0% vs. 97.5%, p = 0.760) between the PED Shield and PED/PED Flex group. For angiographic outcomes, 121 pairs were matched. No significant differences were observed in complete occlusion (80.2% vs. 73.6%, p = 0.223), significant in-stent stenosis (ISS, ISS rate > 50%) (3.3% vs. 5.0%, p = 0.749) and symptomatic ISS (0.0% vs. 2.5%, p = 0.247) between the PED Shield and PED/PED Flex group. However, PED Shield had a lower incidence of ISS (ISS rate ≥ 25%, 5.0 vs. 14.9%, p = 0.010) at a mean follow-up time of 6–7 months. Conclusion Compared with PED/PED Flex, PED Shield has a lower rate of ISS at a mean follow-up time of 6–7 months. No significant differences are observed in perioperative complications, clinical outcomes, complete occlusion, significant ISS and symptomatic ISS. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT06446778.

  • Open Access

    Single‐Nucleus and Multiomics Profiling of Epicardial Adipose Tissue in Atrial Fibrillation Reveals Novel Mechanisms and Translational Biomarkers

    by Shengkang Huang, Ziang Yang, Xin Zhong, Cheng Li, Jinyu Zhen, Xiaocheng Cai, Yuan Gao, Rongxuan Liang, Huilin Wu, Zhaojun Wang, et al.

    Background: Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and imposes a substantial clinical burden. Epicardial adipose tissue (EAT), the cardiac visceral fat depot, has been implicated in AF pathogenesis, but the cellular, molecular, and immune features underlying EAT‐mediated AF remain elusive. Methods: We combined population‐based analysis, Mendelian randomization, single‐nucleus RNA sequencing, and biomarker validation. The visceral adipose tissue–AF association was examined in the National Health and Nutrition Examination Survey, genetic evidence was evaluated using Mendelian randomization based on UKB (UK Biobank), EAT was profiled in patients with coronary artery disease (6 with AF, 3 without), and key circulating signals were evaluated in the Fuwai Hospital cohort and UKB. Results: Higher visceral adipose tissue was associated with increased AF risk in National Health and Nutrition Examination Survey, and Mendelian randomization provided genetic evidence consistent with a potential causal contribution of visceral adipose tissue to AF. Single‐nucleus RNA sequencing showed extensive EAT remodeling in patients with coronary artery disease and AF, including impaired neuroprotective and myelin‐maintenance programs, metabolic imbalance, profibrotic activation, and a chronic inflammatory milieu with immunoglobulin G–related humoral immune activation. Drug2cell prioritized candidate drug–cell associations across specific EAT cell populations, and summary data–based Mendelian randomization prioritized PTPRN2 as a putative AF susceptibility gene. Higher plasma interleukin‐17 levels were associated with postoperative AF in the Fuwai Hospital cohort, whereas circulating interleukin‐17C and interleukin‐17D were independently associated with incident AF in the UKB. Conclusions: We constructed the first single‐nucleus transcriptomic atlas of human AF‐related EAT and identified potential mechanisms linking EAT remodeling to arrhythmogenesis. Elevated plasma interleukin‐17 may serve as a predictive biomarker for AF.

  • Open Access

    Local pressure as a dominant hemodynamic driver of wall enhancement in anterior communicating artery aneurysms: a facet-level computational fluid dynamics and vessel wall imaging analysis

    by Zhangyu Pang, Chi Huang, Jingtao Ma, Hui Tang, Xiaojing Guo, Yao Zhang, Kaiyan Tan, Linhan Yan, Zhengjie Fang, Qian Wu, et al.

    Background: Size-based risk stratification often overlooks small but unstable intracranial aneurysms (IAs). Aneurysm wall enhancement (AWE) on vessel wall imaging (VWI) is a validated marker of wall instability, yet the local hemodynamic drivers of this pathology, particularly in complex anterior communicating artery (ACoA) aneurysms, remain incompletely characterized. This study leverages a combined computational fluid dynamics (CFD)-VWI approach to characterize the mechanobiological coupling between local hemodynamics and quantitative wall remodeling in ACoA aneurysms. Methods: We retrospectively analyzed 24 patients harboring 25 ACoA aneurysms. A Vector-Integrated Surface Parametrization (VISP) pipeline achieved sub-voxel sampling density [through adaptive interpolation rather than imaging resolution beyond the native 0.6 mm magnetic resonance imaging (MRI) voxel] for co-registration of CFD and 3T-VWI, with wall enhancement defined at a contrast ratio (CR) ≥0.6. To identify hemodynamic drivers of enhanced wall thickness (EWT) while explicitly accounting for within-patient hierarchical clustering, four complementary analytical frameworks were applied in parallel: (I) intra-patient paired bootstrap tests (2,000 resamples) comparing enhanced and non-enhanced wall segments within each of the 13 AWE-positive patients; (II) a multivariate linear mixed model (LMM) with patient-level random intercepts for EWT severity (n=12,473 enhanced segments); (III) generalized estimating equations (GEEs) with cluster-robust variance for AWE presence (n=157,284 segments); and (IV) ensemble machine-learning models (Random Forest and XGBoost) interpreted via Shapley Additive exPlanations (SHAP) values across segment-level, patient-centered, and patient-level GroupKFold cross-validation (CV). Cross-patient generalization of EWT prediction was disclosed separately as an out-of-sample analysis. Results: Focal AWE was identified in 14 of 25 aneurysms (13 patients), spatially coinciding with hemodynamic stagnation zones. Enhanced segments exhibited significantly lower local Pressurepeak (∆ =−35.25 Pa, PFDR =0.02) and wall shear stress (WSS)peak (∆ =−3.97 Pa, PFDR <0.001) compared to non-enhanced segments under intra-patient paired bootstrap testing. Three further frameworks converged on Pressurepeak as the dominant independent driver of wall thickness among enhanced segments: multivariate LMM β=−0.181 (P=2.31×10−11); GEE β=−0.5452 (robust P=0.0499); and a Random Forest model, in which Pressurepeak ranked first by SHAP feature importance at the segment level and remained among the top three across every CV regime. Conclusions: We present a facet-level CFD-VWI pipeline that achieves sub-voxel sampling density for spatially mapping local hemodynamics onto quantitative wall remodeling in ACoA aneurysms on a clinical 3T platform. Across four independent hierarchical analyses, local Pressurepeak consistently emerged as the dominant independent hemodynamic driver of wall thickening among enhanced segments, complementing the established low-WSS association. This framework is intended as a mechanistic explanatory tool for local hemodynamic-AWE coupling; broader clinical translation will require larger, externally validated cohorts.

  • Development and validation of the FLATS score to predict periprocedural ischemic events after stent-assisted coiling for ruptured intracranial aneurysms in the acute phase: a nationwide chinese registry

    by Chi Huang, Hailong Zhong, Yiming Bi, Weiming Zhong, Zhuohua Wen, Yihan Chen, Chenxi Duan, Yueyi Zhang, Mengshi Huang, Zhicen Li, et al.

    Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating stroke subtype. In the acute phase (< 72 h), stent-assisted coiling (SAC) carries a

  • Association Between the Systemic Immune‐Inflammation Index and Aneurysmal Wall Enhancement on High‐Resolution Magnetic Resonance Vessel Wall Imaging in Unruptured Intracranial Aneurysms

    by Jiwan Huang, Runze Ge, Caihong Li, Yuxin Li, Zhuohua Wen, Chi Huang, Anqi Xu, Mengshi Huang, Jiancheng Lin, Hao Yuan, et al.

    Background: Inflammation is a critical driver of intracranial aneurysm (IA) instability. The systemic immune‐inflammation index (SII), a novel composite inflammatory biomarker, may reflect the local mural changes observed on vessel wall imaging (VWI). Purpose/Hypothesis: To investigate the association between the SII and aneurysmal wall enhancement (AWE) on high‐resolution vessel wall imaging (HRVWI), and to evaluate SII as a potential biomarker for aneurysm instability. Study Type: Prospective cross‐sectional study. Population: Four hundred and eighteen intracranial aneurysms in 311 patients (65.3% female, median age 58.0 years) underwent HRVWI. A sub‐cohort of 67 patients with 84 aneurysms was included for longitudinal analysis of aneurysm growth (median follow‐up 7.0 months). Field Strength/Sequence: Field strength/sequence: A 3.0T MR scanner; 3D time‐of‐flight magnetic resonance angiography (TOF‐MRA); 3D black‐blood T1‐weighted volumetric turbo spin echo acquisition (T1‐VISTA); and post‐contrast vessel wall imaging using a 3D fast field echo sequence. Assessment: AWE defined as aneurysm‐to‐pituitary stalk contrast ratio (CR stalk ) ≥ 0.60. SII was calculated from admission blood counts as (platelet count * neutrophil count)/(lymphocyte count * 1000). Statistical Tests: Multivariable logistic regression and propensity score matching evaluated the association between SII and AWE. Longitudinal analysis was performed using Firth's logistic regression. Subgroup analyses were stratified by clinical and aneurysmal characteristics. p < 0.05 was considered significant. Results: AWE was present in 142/418 (34.0%) aneurysms. In multivariable analysis, elevated SII was independently associated with AWE (odds ratio [OR] = 1.93). This association remained significant after PSM (median SII: 0.60 in AWE group vs. 0.42 in non‐AWE group). SII was also independently associated with aneurysm growth in the longitudinal sub‐cohort (OR = 20.519). Subgroup analysis showed a significant interaction with aneurysm location, with the strongest association in the internal carotid artery (OR = 3.55; 95% CI: 1.63–7.71). Data Conclusion: Elevated SII is independently associated with the presence of AWE and aneurysm growth. Evidence Level: 3. Technical Efficacy: Stage 2.


  • Open Access

    H-Type Hypertension and Aneurysm Instability: An Observational and Genetic Study

    by Ji-Wan Huang, Hao Yuan, Rui-Yan Liu, Xue-Yan Deng, Cai-Hong Li, Yu-Xin Li, Bo-Han Cai, Le-Le Dai, Wen-Xin Chen, Chi Huang, et al.

    Background: Unruptured intracranial aneurysms (UIAs) pose a significant risk of subarachnoid hemorrhage. Both hypertension and hyperhomocysteinemia are recognized as independent risk factors for vascular disease; however, their combined impact (H-type hypertension) on aneurysm instability and rupture remains unclear. Methods: We analyzed a prospective cohort of 358 adults with UIAs (475 aneurysms) using high-resolution vessel-wall MRI (HRVWI) for cross-sectional and longitudinal assessment. H-type hypertension was defined as hypertension with plasma homocysteine ≥10 μmol/L. Multivariable logistic regression assessed associations with AWE and aneurysm growth (longitudinal sub-cohort: n = 82, 89 aneurysms). Mendelian randomization (MR) analyses evaluated the causal role of homocysteine in hypertension and aSAH. Proteomic profiling identified potential molecular mechanisms. Results: AWE occurred in 33.7% of aneurysms, which were larger, irregular, and had higher PHASES scores. Elevated homocysteine (10.3 vs 9.5 μmol/L, p = 0.004) and H-type hypertension (43.8% vs 28.3%, p < 0.001) were associated with AWE. After adjustment, H-type hypertension independently predicted AWE (OR = 3.18) and aneurysm growth (OR = 3.63). MR analyses showed homocysteine increased aSAH (OR = 1.39) and hypertension risk (OR = 1.10), while hypertension increased aSAH risk (OR = 1.58). Mediation analysis did not support hypertension as a mediator (p = 0.20). Proteomic analyses identified key pathways related to inflammation–immune dysregulation, extracellular matrix remodeling, and signaling activation as potential mediators. Conclusions: H-type hypertension amplifies aneurysmal-wall instability and growth. Combined control of blood pressure and homocysteine merits prospective evaluation for UIA prevention.

  • Sex difference in predictors of aneurysmal wall enhancement: a cross-sectional and prospective cohort study

    by Runze Ge, Jiwan Huang, Caihong Li, Yuxin Li, Zhuohua Wen, Anqi Xu, Mengshi Huang, Jiancheng Lin, Hao Yuan, Hongyu Shi, et al.

    Background Aneurysm wall enhancement (AWE) is a potential imaging biomarker that can be used to identify intracranial aneurysms with an increased risk of rupture. Factors and mechanisms causing intracranial aneurysms to rupture or progress differ between women and men. Thus, we performed a cross-sectional and prospective cohort study to identify the risk factors predicting AWE in men and women. Methods Consecutive patients with unruptured intracranial aneurysms were prospectively recruited from September 2022 to September 2024. Baseline characteristics were collected through a standard questionnaire. Multivariate logistic regression was performed to assess the predictors of aneurysmal wall enhancement in men and women. Results A total of 332 patients with 435 intracranial aneurysms were included. In the multiple logistic regression analysis, obesity (OR = 2.88, 95% CI 1.06–7.81, P = 0.038), the history of hypertension (OR = 2.76, 95% CI 1.16–6.57, P = 0.022) and younger age (OR = 0.96, 95% CI 0.93-1.00, p = 0.035) were independent risk factors for AWE in men. Meanwhile, drinking habit (OR = 2.64, 95% CI 1.09–6.41, P = 0.032), the family history of intracranial aneurysm (OR = 4.01, 95% CI 1.21–13.36, P = 0.024) and older age (OR = 1.04, 95% CI 1.01–1.07, P = 0.009) were independent risk factors for AWE in women. Conclusion This study clearly demonstrates a significant sexual dimorphism in the risk factors associated with AWE. These findings underscore the necessity for sex-specific risk stratification models for intracranial aneurysm management, suggesting that men and women have specific lifestyle interventions to prevent the progression or rupture of intracranial aneurysms.